Stephen L. Graziano

7.5k total citations
117 papers, 5.2k citations indexed

About

Stephen L. Graziano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Stephen L. Graziano has authored 117 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 31 papers in Molecular Biology. Recurrent topics in Stephen L. Graziano's work include Lung Cancer Treatments and Mutations (56 papers), Lung Cancer Research Studies (43 papers) and Lung Cancer Diagnosis and Treatment (25 papers). Stephen L. Graziano is often cited by papers focused on Lung Cancer Treatments and Mutations (56 papers), Lung Cancer Research Studies (43 papers) and Lung Cancer Diagnosis and Treatment (25 papers). Stephen L. Graziano collaborates with scholars based in United States, Canada and France. Stephen L. Graziano's co-authors include Nancy Newman, Leslie J. Kohman, Gary P. Gamble, Ajeet Gajra, Mark R. Green, Lesley Seymour, Frances A. Shepherd, Jean‐Charles Soria, Ming‐Sound Tsao and Gwénaël Le Teuff and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Stephen L. Graziano

116 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen L. Graziano United States	39	2.9k	2.8k	1.3k	695	559	117	5.2k
Kiyotaka Yoh Japan	35	2.6k 0.9×	3.0k 1.1×	1.4k 1.1×	740 1.1×	562 1.0×	271	4.6k
Antonio Chella Italy	39	3.5k 1.2×	2.9k 1.0×	1.6k 1.3×	1.2k 1.7×	307 0.5×	130	5.5k
Y Ariyoshi Japan	31	2.8k 1.0×	3.2k 1.2×	2.0k 1.6×	427 0.6×	697 1.2×	127	5.5k
Akira Sakurada Japan	31	3.3k 1.1×	2.6k 0.9×	1.8k 1.4×	848 1.2×	418 0.7×	189	5.4k
Gérard Zalcman France	39	3.0k 1.1×	3.5k 1.2×	2.1k 1.7×	890 1.3×	420 0.8×	299	6.7k
Seiji Niho Japan	37	3.0k 1.0×	3.2k 1.2×	1.1k 0.9×	547 0.8×	894 1.6×	213	5.1k
Sylvie Lantuéjoul France	45	3.7k 1.3×	3.2k 1.2×	2.1k 1.7×	1.2k 1.8×	981 1.8×	154	6.9k
Siow Ming Lee United Kingdom	38	2.0k 0.7×	2.4k 0.9×	1.6k 1.3×	547 0.8×	695 1.2×	171	4.9k
Daniel Betticher Switzerland	38	2.2k 0.8×	2.4k 0.9×	1.7k 1.3×	850 1.2×	251 0.4×	154	5.5k
Lizza Hendriks Netherlands	36	3.0k 1.0×	3.2k 1.2×	820 0.7×	587 0.8×	538 1.0×	221	5.1k

Countries citing papers authored by Stephen L. Graziano

Since Specialization

Citations

This map shows the geographic impact of Stephen L. Graziano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen L. Graziano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen L. Graziano more than expected).

Fields of papers citing papers by Stephen L. Graziano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen L. Graziano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen L. Graziano. The network helps show where Stephen L. Graziano may publish in the future.

Co-authorship network of co-authors of Stephen L. Graziano

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen L. Graziano. A scholar is included among the top collaborators of Stephen L. Graziano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen L. Graziano. Stephen L. Graziano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Roger, et al.. (2024). Comparative survival after neoadjuvant vs adjuvant systemic therapy in resectable stage II and stage III non-small cell lung cancer: A retrospective study using the National Cancer Database.. Journal of Clinical Oncology. 42(16_suppl). 8075–8075. 1 indexed citations

Goodman, Alexandra, et al.. (2024). Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research. Frontiers in Oncology. 14. 1411432–1411432. 1 indexed citations

Steuer, Conor, Opeyemi A. Jegede, Suzanne E. Dahlberg, et al.. (2021). Smoking Behavior in Patients With Early-Stage NSCLC: A Report From ECOG-ACRIN 1505 Trial. Journal of Thoracic Oncology. 16(6). 960–967. 8 indexed citations

Tsao, Ming‐Sound, Gwénaël Le Teuff, Frances A. Shepherd, et al.. (2017). PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer. Annals of Oncology. 28(4). 882–889. 96 indexed citations

Ma, Xiaoli, Gwénaël Le Teuff, Benjamin Lacas, et al.. (2016). Prognostic and Predictive Effect of TP53 Mutations in Patients with Non–Small Cell Lung Cancer from Adjuvant Cisplatin–Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis. Journal of Thoracic Oncology. 11(6). 850–861. 77 indexed citations

Singh, Anurag K., et al.. (2013). Biclonal Chronic Lymphocytic Leukemia Presenting as Skin Lesion. American Journal of Dermatopathology. 36(3). 260–262. 1 indexed citations

Ready, Neal, Arkadiusz Z. Dudek, Herbert Pang, et al.. (2011). Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study. Journal of Clinical Oncology. 29(33). 4436–4441. 71 indexed citations

Graziano, Stephen L., James E. Herndon, Mark A. Socinski, et al.. (2008). Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901. Journal of Thoracic Oncology. 3(2). 158–162. 15 indexed citations

Gajra, Ajeet, et al.. (2007). Expression of the glutathione-S-transferase π (GST-π) protein correlates with survival in patients with stage I non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 21065–21065. 1 indexed citations

10.

Anker, Christopher J., et al.. (2006). Brain: The Common Site of Relapse in Patients with Pancoast or Superior Sulcus Tumors. Journal of Thoracic Oncology. 1(9). 1020–1022. 9 indexed citations

11.

Gajra, Ajeet, Arthur H. Tatum, Nancy Newman, et al.. (2002). The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 36(2). 159–165. 36 indexed citations

12.

Graziano, Stephen L., Arthur H. Tatum, James E. Herndon, et al.. (2001). Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: a Cancer and Leukemia Group B study. Lung Cancer. 33(2-3). 115–123. 50 indexed citations

13.

Mehdi, Syed A., Arthur H. Tatum, Nancy Newman, et al.. (1999). Prognostic Markers in Resected Non–Small-Cell Lung Cancer: An Patients with 5 Year Follow-Up. Clinical Lung Cancer. 1(1). 59–67. 26 indexed citations

14.

Choy, H., Wallace Akerley, Howard Safran, et al.. (1998). Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(10). 3316–3322. 190 indexed citations

15.

Graziano, Stephen L., Jeffrey A. Kern, James E. Herndon, et al.. (1998). Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: A Cancer and Leukemia Group B study. Lung Cancer. 21(3). 203–211. 25 indexed citations

16.

Mehdi, Syed A., et al.. (1998). Prognostic Significance of Lewis y Antigen in Resected Stage I and II Non-small Cell Lung Cancer. CHEST Journal. 114(5). 1309–1315. 13 indexed citations

17.

Marchioli, C C & Stephen L. Graziano. (1997). PARANEOPLASTIC SYNDROMES ASSOCIATED WITH SMALL CELL LUNG CANCER. Chest Surgery Clinics of North America. 7(1). 65–80. 27 indexed citations

18.

Feld, Ronald, Raymond P. Abratt, Stephen L. Graziano, et al.. (1997). Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer. 17. S3–S10. 35 indexed citations

19.

Choy, H., et al.. (1996). Concurrent Paclitaxel and Radiation Therapy for Solid Tumors. Cancer Control. 3(4). 310–318. 14 indexed citations

20.

Latif, Farida, Kálmán Tory, William S. Modi, et al.. (1992). Molecular characterization of a large homozygous deletion in the small cell lung cancer cell line U2020: A strategy for cloning the putative tumor suppressor gene. Genes Chromosomes and Cancer. 5(2). 119–127. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact